Company news

Caris Life Sciences, Inc. news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Caris Life Sciences Reports Third Quarter 2025 Financial Results and Increases 2025 Revenue Guidance

November 4, 2025

Caris Data Validates TET2 Clonal Hematopoiesis as a Biomarker for Enhanced Immunotherapy Response

October 28, 2025

Caris Life Sciences to Report Third Quarter 2025 Financial Results on November 5, 2025

October 22, 2025

Caris Life Sciences to Share Six Collaborative Studies at ESMO 2025

October 13, 2025

Caris Life Sciences Demonstrates Scientific Rigor with Clinical Validation of FDA-Approved MI Cancer Seek®

August 14, 2025

New Study from Caris Life Sciences Validates Optimal Sequencing in Informing Therapy Choices for Breast Cancer Subgroups

August 13, 2025

Caris Life Sciences Reports Second Quarter 2025 Financial Results

August 12, 2025

Caris Life Sciences Publishes Study Showing AI Signature-positive Breast Cancer Patients Live Almost Twice as Long as AI-negative Patients When Treated with a Checkpoint Inhibitor

August 6, 2025

Caris Life Sciences Publishes Study Showing its Multi-Layer AI-Based Tissue of Origin Predictions are Best-in-Class and Identify when Patients have been Misdiagnosed

August 5, 2025

Caris Life Sciences to Report Second Quarter 2025 Financial Results on August 12, 2025

July 23, 2025

Caris Life Sciences Validates and Extends Findings on Tumor-Infiltrating Clonal Hematopoiesis

July 22, 2025

Caris Life Sciences Announces New Study Demonstrating the Power and Clinical Utility of its Caris Assure® Blood-Based Assay for Multi-Cancer Early Detection, Minimal Residual Disease and Therapy Selection

July 8, 2025

← Newer news releases

Calls

Decks

The 5 newest of 10 decks. Every deck is listed under its year.